![](https://www.Immune-System-Research.com/"wp-content/uploads"/2023/06/SB-435495-is-an-Orally-Active-Lp-PLA2-Inhibitor-for-Diabetes-Research-20230601.jpg)
Lp-PLA2 (Lipoprotein-associated phospholipase A2) is a calcium-independent serine lipase of 50-kDa that hydrolyzes the acetyl group at the sn-2 position…
Darapladib (SB-480848) is a potent, selective, freely reversible, non-covalently bound, orally active inhibitor of Lp-PLA2 with an IC50 of 0.25 nM, and…